Efegatran sulfate

CAS No. 126721-07-1

Efegatran sulfate( —— )

Catalog No. M34072 CAS No. 126721-07-1

Efegatran sulfate (LY294468 sulfate) is a potent thrombin inhibitor used in the treatment of thrombotic disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 818 Get Quote
5MG 1140 Get Quote
10MG 1511 Get Quote
25MG 2199 Get Quote
50MG 2972 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Efegatran sulfate
  • Note
    Research use only, not for human use.
  • Brief Description
    Efegatran sulfate (LY294468 sulfate) is a potent thrombin inhibitor used in the treatment of thrombotic disorders.
  • Description
    Efegatran sulfate (LY294468 sulfate) is a potent thrombin inhibitor used in the treatment of thrombotic disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    Thrombin
  • Recptor
    Thrombin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    126721-07-1
  • Formula Weight
    514.6
  • Molecular Formula
    C21H34N6O7S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(=O)(=O)(O)O.C([C@@H](CC1=CC=CC=C1)NC)(=O)N2[C@H](C(N[C@@H](CCCNC(=N)N)C=O)=O)CCC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ximelagatran

    Ximelagatran, a direct thrombin inhibitor, can be taken orally and acts solely by inhibiting the actions of thrombin. Ximelagatran is converted to the active agent melagatran in vivo.

  • Pirodomast

    Pirodomast is a thromboxane A (TXA2) synthase inhibitor.

  • Imitrodast

    Imitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.